{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:11:23Z","timestamp":1785352283077,"version":"3.55.0"},"reference-count":7,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,19]]},"DOI":"10.1093\/ibd\/izaa176","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T12:36:00Z","timestamp":1593779760000},"page":"e161-e162","source":"Crossref","is-referenced-by-count":14,"title":["De novo Anti-TNF-\u03b1-induced Congestive Heart Failure in a Patient With Turner Syndrome and Crohn\u2019s Disease"],"prefix":"10.1093","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1466-8752","authenticated-orcid":false,"given":"Eoin","family":"Keating","sequence":"first","affiliation":[{"name":"Gastroenterology Department, Mater Misericordiae University Hospital , Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T Barry","family":"Kelleher","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, Mater Misericordiae University Hospital , Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor","family":"Lahiff","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, Mater Misericordiae University Hospital , Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,7,3]]},"reference":[{"key":"2022092715490730700_CIT0001","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ejim.2012.12.015","article-title":"Heart failure and anti tumor necrosis factor-alpha in systemic chronic inflammatory diseases","volume":"24","author":"Sinagra","year":"2013","journal-title":"Eur J Intern Med."},{"key":"2022092715490730700_CIT0002","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","article-title":"Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial","volume":"107","author":"Chung","year":"2003","journal-title":"Circulation."},{"key":"2022092715490730700_CIT0003","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0167-5273(02)00470-9","article-title":"How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH","volume":"86","author":"Anker","year":"2002","journal-title":"Int J Cardiol."},{"key":"2022092715490730700_CIT0004","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1136\/ard.2005.043166","article-title":"Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis","volume":"65","author":"Schiff","year":"2006","journal-title":"Ann Rheum Dis."},{"key":"2022092715490730700_CIT0005","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0022-3476(98)70119-2","article-title":"Congenital heart disease in patients with Turner\u2019s syndrome. Italian Study Group for Turner Syndrome (ISGTS)","volume":"133","author":"Mazzanti","year":"1998","journal-title":"J Pediatr."},{"key":"2022092715490730700_CIT0006","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2165\/00129784-200202060-00005","article-title":"Turner syndrome and the heart","volume":"2","author":"Gravholt","year":"2002","journal-title":"Am J Cardiovasc Drug."},{"key":"2022092715490730700_CIT0007","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s40264-019-00797-3","article-title":"Ustekinumab safety in psoriasis, psoriatic arthritis, and Crohn\u2019s disease: an integrated analysis of phase II\/III clinical development programs","volume":"42","author":"Ghosh","year":"2019","journal-title":"Drug Saf."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/26\/12\/e161\/46102058\/izaa176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/26\/12\/e161\/46102058\/izaa176.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T16:31:04Z","timestamp":1664296264000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/26\/12\/e161\/5866903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,3]]},"references-count":7,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,7,3]]},"published-print":{"date-parts":[[2020,11,19]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izaa176","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12]]},"published":{"date-parts":[[2020,7,3]]}}}